PortfoliosLab logo
Bioceres Crop Solutions Corp. (BIOX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

KYG1117K1141

IPO Date

Mar 22, 2018

Highlights

Market Cap

$252.09M

EPS (TTM)

$0.02

PE Ratio

208.50

PEG Ratio

1.01

Total Revenue (TTM)

$323.71M

Gross Profit (TTM)

$128.40M

EBITDA (TTM)

$34.00M

Year Range

$3.51 - $13.10

Target Price

$7.63

Short %

3.85%

Short Ratio

6.08

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Bioceres Crop Solutions Corp., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%December2025FebruaryMarchAprilMay
-53.44%
114.24%
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Returns By Period

Bioceres Crop Solutions Corp. (BIOX) returned -26.48% year-to-date (YTD) and -65.56% over the past 12 months.


BIOX

YTD

-26.48%

1M

20.81%

6M

-31.96%

1Y

-65.56%

5Y*

-5.26%

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of BIOX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202512.66%-41.31%13.56%-6.90%5.18%-26.48%
2024-2.77%-1.65%-3.58%-6.79%-0.17%-4.84%-0.98%-4.14%-26.03%-14.61%5.95%-14.61%-55.72%
20233.91%-7.76%0.69%-3.45%6.42%11.99%-3.52%-4.97%-7.84%-2.21%10.51%12.54%14.13%
2022-10.47%-0.55%8.18%7.20%0.55%-6.61%-23.78%32.82%-6.20%11.06%-4.50%-12.89%-14.92%
202114.68%15.33%24.15%47.35%2.40%-8.53%-0.50%0.07%-3.50%-4.07%15.98%-5.86%128.06%
20202.59%9.27%-13.43%31.02%4.21%-9.42%-10.56%2.21%-3.25%12.87%0.83%1.64%22.80%
20190.20%-44.40%-6.95%-13.41%-8.19%27.71%13.77%-3.48%10.82%-4.19%-7.28%-11.88%-49.86%
2018-0.21%0.73%0.52%-0.10%0.03%0.38%0.21%0.00%2.56%0.70%4.90%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of BIOX is 5, meaning it’s performing worse than 95% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of BIOX is 55
Overall Rank
The Sharpe Ratio Rank of BIOX is 22
Sharpe Ratio Rank
The Sortino Ratio Rank of BIOX is 33
Sortino Ratio Rank
The Omega Ratio Rank of BIOX is 44
Omega Ratio Rank
The Calmar Ratio Rank of BIOX is 55
Calmar Ratio Rank
The Martin Ratio Rank of BIOX is 1111
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Bioceres Crop Solutions Corp. (BIOX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Bioceres Crop Solutions Corp. Sharpe ratios as of May 9, 2025 (values are recalculated daily):

  • 1-Year: -1.13
  • 5-Year: -0.10
  • All Time: -0.18

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

The chart below shows the rolling Sharpe ratio of Bioceres Crop Solutions Corp. compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time. For deeper analysis or to customize the calculation, use the Sharpe ratio tool.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00December2025FebruaryMarchAprilMay
-1.13
0.48
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Dividends

Dividend History


Bioceres Crop Solutions Corp. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-72.06%
-7.82%
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Bioceres Crop Solutions Corp.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Bioceres Crop Solutions Corp. was 76.88%, occurring on Apr 8, 2025. The portfolio has not yet recovered.

The current Bioceres Crop Solutions Corp. drawdown is 72.06%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-76.88%Nov 18, 2021849Apr 8, 2025
-59.41%Dec 13, 2018107May 17, 2019460Mar 16, 2021567
-23.83%May 18, 202120Jun 15, 2021108Nov 16, 2021128
-12.51%Mar 18, 20218Mar 29, 20214Apr 5, 202112
-10.68%Apr 12, 20213Apr 14, 202110Apr 28, 202113

Volatility

Volatility Chart

The current Bioceres Crop Solutions Corp. volatility is 20.72%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%December2025FebruaryMarchAprilMay
20.72%
11.21%
BIOX (Bioceres Crop Solutions Corp.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Bioceres Crop Solutions Corp. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Bioceres Crop Solutions Corp., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -98.2%.


-0.20-0.100.000.100.200.300.40AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
0.00
0.09
Actual
Estimate

Valuation

The Valuation section provides an overview of how Bioceres Crop Solutions Corp. is priced in the market compared to other companies in the Agricultural Inputs industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for BIOX, comparing it with other companies in the Agricultural Inputs industry. Currently, BIOX has a P/E ratio of 208.5. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for BIOX compared to other companies in the Agricultural Inputs industry. BIOX currently has a PEG ratio of 1.0. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for BIOX relative to other companies in the Agricultural Inputs industry. Currently, BIOX has a P/S ratio of 0.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for BIOX in comparison with other companies in the Agricultural Inputs industry. Currently, BIOX has a P/B value of 0.9. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items